Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» obesity
obesity
Orexigen revises obesity drug data; shares fall
Reuters
Wed, 04/14/10 - 10:44 am
obesity
Orexigen
Contrave
New Obesity Pills: The Pipeline Getting Fat?
CNBC
Tue, 04/13/10 - 09:42 am
obesity
Vivus
Qnexa
Arena Pharmaceuticals
Orexigen
Contrave
Orexigen asks FDA for weight-loss drug approval
Yahoo/AP
Wed, 03/31/10 - 09:51 pm
Orexigen
FDA
obesity
Contrave
Vivus
Arena Pharmaceuticals
Qnexa
FDA to Review VIVUS Drug
Yahoo/Zacks.com
Mon, 03/29/10 - 11:23 am
FDA
obesity
Vivus
Orexigen
Arena Pharmaceuticals
Qnexa
Amylin
Bulls Anticipating a Vivus Upside
Seeking Alpha
Sat, 03/27/10 - 11:15 am
Vivus
obesity
Qnexa
Rise in obesity makes VCs hungry for startups
Reuters
Fri, 03/26/10 - 09:10 am
venture capital
obesity
Rhythm Pharmaceuticals
Elixir Medical
FDA panel to review Vivus drug in July
Fierce Biotech
Fri, 03/26/10 - 09:09 am
Vivus
FDA
obesity
Qnexa
3 Ways to Play the Obesity Drugs
TheStreet.com
Tue, 03/16/10 - 10:05 am
obesity
Arena Pharmaceuticals
Vivus
Orexigen
Contrave
Qnexa
lorcaserin
EnteroMedics retools, refocuses to win FDA approval
Med City News
Sat, 03/13/10 - 10:55 am
EnteroMedics
obesity
Maestro
Arena will launch lorcaserin with partner or alone
Reuters
Fri, 03/12/10 - 09:36 am
Arena Pharmaceuticals
obesity
lorcaserin
FDA accepts Vivus application for obesity drug
Marketwatch
Mon, 03/1/10 - 09:57 am
FDA
Vivus
obesity
Qnexa
Amylin’s Other Drug to Watch
Minyanville
Wed, 02/24/10 - 10:10 am
Amylin
Takeda
obesity
[[video]Orexigen CEO Talks Obesity
Yahoo/CNBC
Tue, 02/9/10 - 09:53 am
Pharma CEOs
obesity
Orexigen
Michael Narachi
Takeda Pharma Plans to Sell Obesity Drug in Japan, Nikkei Says
Bloomberg
Mon, 01/25/10 - 09:22 am
Japan
obesity
Takeda
Investors betting heavily on Vivus obesity drug
Marketwatch
Thu, 01/21/10 - 07:49 am
Vivus
obesity
Qnexa
Vivus files application with FDA for obesity drug
Marketwatch
Tue, 12/29/09 - 09:14 am
FDA
Vivus
obesity
Qnexa
Merck Ends deal with Arena
Yahoo/Zacks.com
Mon, 12/28/09 - 10:10 am
Arena Pharmaceuticals
obesity
Merck
atherosclerosis
Orexigen
Arena submits U.S. application for obesity drug
Marketwatch
Tue, 12/22/09 - 09:31 am
obesity
Arena Pharmaceuticals
Obesity Becomes Shionogi’s Gamble for Another Crestor
Bloomberg
Tue, 12/22/09 - 07:54 am
Crestor
obesity
Shionogi
Velneperit
Arena Pharmaceuticals shares fall on Jefferies analyst 'Hold' rating, view on obesity drug
Yahoo/AP
Thu, 12/17/09 - 01:32 pm
obesity
Arena Pharmaceuticals
lorcaserin
Pages
« first
‹ previous
…
40
41
42
43
44
45
46
47
48
next ›
last »